NCT01284608已完成不适用
Metabolic Changes in Prostate Cancer Patients With Androgen-ablation Therapy (AAT)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 197
- 试验地点
- 1
- 主要终点
- Metabolic syndrome
研究概览
简要总结
This is an observational, prospective, non-interventional and multi-centre study, to assess the impact of androgen ablation therapy in blood triglycerides, cholesterol and glucose, body fat distribution and fracture risk to ten years using FRAX model in patients with prostate cancer. The patients will be following for 12 months
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •Prostate cancer patient requiring androgen-ablation treatment: LHRH analogs, surgical castration, antiandrogen treatment
- •Provision of informed consent prior to conducting any study-related procedure
排除标准
- •Patient involved in a Clinical Trial
结局指标
主要结局
Metabolic syndrome
时间窗: 12 months
Diabetes
时间窗: 12 months
次要结局
- Fracture Risk Assessment Tool (FRAx) assessment(0 and 12 months)
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Prostate Metabolism, Cancer Risk and Gut MicrobiotaProstate HyperplasiaProstate CancerNCT06116851Turku University Hospital300
Unknown
不适用
Fasting Mimicking Diet in Prostate Cancer and Metabolic SyndromeMetabolic SyndromeIntermittent FastingProstate CancerNCT04292041Galway Clinic40
已完成
不适用
A Study to Observe Demography and the Outcome of Prostate Cancer Patients Treated With 6-month Triptorelin Formulation in ItalyProstate CancerNCT05759273Ipsen167
招募中
不适用
Metabolomics of prostate cancer patients to identify diagnostic and prognostic biomarkersCTRI/2023/01/048921AIIMS New Delhi
已完成
2 期
Metabolic Change in Prostate Cancer Bone Metastases on 68Ga-HBED-CC-PSMA PET/CT Following Radium-223 TherapyProstate CancerNCT03062254Sir Mortimer B. Davis - Jewish General Hospital14